Funding Received
$75 Million in 5 Rounds from 9 Investors
Most Recent Funding
$14.5 Million Series A on April 8, 2014
Headquarters:
Cambridge, MA
Description:
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Categories:
Biotechnology
Website:
http://www.mersana.com

Company Details

Update

Mersana Therapeutics employs its biodegradable polymer platform (Fleximer®) to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. They also leverage the versatility of Fleximer through partnerships to overcome the safety, efficacy, and delivery challenges of nucleic acids, biologics, and small molecules in numerous therapeutic areas.

Current Team (8)

Update

Past Team (3)

Update

Board Members and Advisors (9)

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Office

    840 Memorial Drive

    Cambridge, MA 02139

    USA

Images (2)

Update
  • C3u00xfydfrmbdb9d3gi
  • 115fcd6dd10a830308ec7b7f89d59ea8